CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Kaleido Biosciences, Inc. - KLDO CFD

0.38
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.05
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.39
Open* 0.4
1-Year Change* 2.56%
Day's Range* 0.38 - 0.45
52 wk Range 0.00-1.92
Average Volume (10 days) 26.79K
Average Volume (3 months) 306.37K
Market Cap 8,520.00
P/E Ratio -100.00K
Shares Outstanding 42.62M
Revenue 1.10M
EPS -2.16
Dividend (Yield %) N/A
Beta 0.47
Next Earnings Date Mar 23, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 14, 2022 0.38 0.00 0.00% 0.38 0.38 0.38
Apr 13, 2022 0.39 0.00 0.00% 0.39 0.47 0.38
Apr 8, 2022 0.40 -0.24 -37.50% 0.64 0.64 0.38
Apr 7, 2022 1.46 -0.01 -0.68% 1.47 1.55 1.42
Apr 6, 2022 1.46 -0.02 -1.35% 1.48 1.48 1.42
Apr 5, 2022 1.50 -0.09 -5.66% 1.59 1.62 1.48
Apr 4, 2022 1.59 -0.14 -8.09% 1.73 1.73 1.54
Apr 1, 2022 1.68 0.06 3.70% 1.62 1.70 1.58
Mar 31, 2022 1.60 -0.08 -4.76% 1.68 1.72 1.55
Mar 30, 2022 1.69 -0.14 -7.65% 1.83 1.83 1.69
Mar 29, 2022 1.70 0.02 1.19% 1.68 1.77 1.60
Mar 28, 2022 1.60 -0.13 -7.51% 1.73 1.73 1.50
Mar 25, 2022 1.64 -0.10 -5.75% 1.74 1.74 1.63
Mar 24, 2022 1.74 0.00 0.00% 1.74 1.76 1.68
Mar 23, 2022 1.74 0.01 0.58% 1.73 1.81 1.73
Mar 22, 2022 1.75 0.10 6.06% 1.65 1.75 1.65
Mar 21, 2022 1.63 -0.05 -2.98% 1.68 1.68 1.55
Mar 18, 2022 1.67 0.14 9.15% 1.53 1.71 1.53
Mar 17, 2022 1.56 0.14 9.86% 1.42 1.57 1.42
Mar 16, 2022 1.42 0.04 2.90% 1.38 1.42 1.31

Kaleido Biosciences, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 1.104 0.975 0 0 0
Total Operating Expense 88.771 79.849 87.24 60.683 27.03
Selling/General/Admin. Expenses, Total 20.968 23.882 22.428 18.621 6.038
Research & Development 67.803 55.967 64.232 42.062 20.992
Operating Income -87.667 -78.874 -87.24 -60.683 -27.03
Interest Income (Expense), Net Non-Operating -2.766 -2.553 0.968 -0.805 -0.512
Other, Net 0.145 -0.193 -0.059 -0.256 -0.017
Net Income Before Taxes -90.288 -81.62 -86.331 -61.744 -27.559
Net Income After Taxes -90.288 -81.62 -86.331 -61.744 -27.559
Net Income Before Extra. Items -90.288 -81.62 -86.331 -61.744 -27.559
Net Income -90.288 -81.62 -86.331 -61.744 -27.559
Income Available to Common Excl. Extra. Items -90.288 -81.62 -86.331 -61.744 -27.559
Income Available to Common Incl. Extra. Items -90.288 -81.62 -86.331 -61.744 -27.559
Diluted Net Income -90.288 -81.62 -86.331 -61.744 -27.559
Diluted Weighted Average Shares 41.86 33.4502 25.7033 29.3948 29.3948
Diluted EPS Excluding Extraordinary Items -2.1569 -2.44004 -3.35876 -2.10051 -0.93755
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -2.1569 -2.44004 -3.33619 -2.10051 -0.93755
Unusual Expense (Income) 0 0.58
Revenue 1.104 0.975
Dec 2021 Sep 2021 Jun 2021 Mar 2021 Dec 2020
Total revenue 0.492 0.104 0.211 0.297 0.243
Revenue 0.492 0.104 0.211 0.297 0.243
Total Operating Expense 20.191 22.517 23.418 22.645 19.543
Selling/General/Admin. Expenses, Total 4.617 5.106 5.785 5.46 5.205
Research & Development 15.574 17.411 17.633 17.185 14.338
Unusual Expense (Income) 0
Operating Income -19.699 -22.413 -23.207 -22.348 -19.3
Interest Income (Expense), Net Non-Operating -0.705 -0.692 -0.681 -0.688 -0.713
Other, Net 0.132 0.02 -0.001 -0.006 -0.003
Net Income Before Taxes -20.272 -23.085 -23.889 -23.042 -20.016
Net Income After Taxes -20.272 -23.085 -23.889 -23.042 -20.016
Net Income Before Extra. Items -20.272 -23.085 -23.889 -23.042 -20.016
Net Income -20.272 -23.085 -23.889 -23.042 -20.016
Income Available to Common Excl. Extra. Items -20.272 -23.085 -23.889 -23.042 -20.016
Income Available to Common Incl. Extra. Items -20.272 -23.085 -23.889 -23.042 -20.016
Diluted Net Income -20.272 -23.085 -23.889 -23.042 -20.016
Diluted Weighted Average Shares 42.5995 42.5776 42.5386 39.6926 35.9841
Diluted EPS Excluding Extraordinary Items -0.47587 -0.54219 -0.56158 -0.58051 -0.55625
Diluted Normalized EPS -0.47587 -0.54219 -0.56158 -0.58051 -0.55625
Dividends per Share - Common Stock Primary Issue 0 0 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 42.311 48.721 73.279 76.243 28.551
Cash and Short Term Investments 38.474 46.222 71.241 76.086 28.456
Cash & Equivalents 38.474 46.222 71.241 76.086 28.456
Total Receivables, Net 0.005 0.045
Prepaid Expenses 3.583 2.499 2.038 0.152 0.05
Total Assets 50.137 59.344 82.306 85.325 30.747
Property/Plant/Equipment, Total - Net 5.665 8.462 6.742 4.693 1.975
Property/Plant/Equipment, Total - Gross 11.136 11.955 9.281 5.914 2.406
Accumulated Depreciation, Total -5.471 -3.493 -2.539 -1.221 -0.431
Other Long Term Assets, Total 2.161 2.161 2.285 4.389 0.221
Total Current Liabilities 29.682 16.659 10.377 11.301 3.854
Accounts Payable 5.67 5.389 2.016 3.442 0.864
Accrued Expenses 6.686 7.356 7.086 7.406 2.615
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 16.144 2.634 0.068 0.091 0.104
Other Current Liabilities, Total 1.182 1.28 1.207 0.362 0.271
Total Liabilities 39.53 38.848 33.423 28.343 21.932
Total Long Term Debt 5.55 18.375 20.391 14.831 14.81
Long Term Debt 5.55 18.375 20.391 14.831 14.81
Other Liabilities, Total 4.298 3.814 2.655 2.211 3.268
Total Equity 10.607 20.496 48.883 56.982 8.815
Preferred Stock - Non Redeemable, Net 153.226 52.494
Common Stock 0.043 0.036 0.03 0.006 0.005
Additional Paid-In Capital 375.031 294.639 241.412 9.978 0.8
Retained Earnings (Accumulated Deficit) -364.467 -274.179 -192.559 -106.228 -44.484
Total Liabilities & Shareholders’ Equity 50.137 59.344 82.306 85.325 30.747
Total Common Shares Outstanding 42.596 36.0228 30.1278 29.3948 29.3948
Redeemable Preferred Stock 0 0
Other Current Assets, Total 0.254
Dec 2021 Sep 2021 Jun 2021 Mar 2021 Dec 2020
Total Current Assets 42.311 58.304 74.603 95.032 48.721
Cash and Short Term Investments 38.474 55.657 71.979 92.362 46.222
Cash & Equivalents 38.474 55.657 71.979 92.362 46.222
Prepaid Expenses 3.583 2.647 2.624 2.67 2.499
Total Assets 50.137 67.804 84.29 105.026 59.344
Property/Plant/Equipment, Total - Net 5.665 7.339 7.526 7.833 8.462
Property/Plant/Equipment, Total - Gross 11.136 12.482 12.165 11.889 11.955
Accumulated Depreciation, Total -5.471 -5.143 -4.639 -4.056 -3.493
Other Long Term Assets, Total 2.161 2.161 2.161 2.161 2.161
Total Current Liabilities 29.682 19.261 12.269 12.873 16.659
Accounts Payable 5.67 3.559 2.695 2.412 5.389
Accrued Expenses 6.686 8.681 5.014 4.403 7.356
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 16.144 6.384 3.667 4.759 2.634
Other Current Liabilities, Total 1.182 0.637 0.893 1.299 1.28
Total Liabilities 39.53 38.604 34.024 33.252 38.848
Total Long Term Debt 5.55 15.132 17.677 16.433 18.375
Long Term Debt 5.55 15.132 17.677 16.433 18.375
Other Liabilities, Total 4.298 4.211 4.078 3.946 3.814
Total Equity 10.607 29.2 50.266 71.774 20.496
Common Stock 0.043 0.043 0.043 0.042 0.036
Additional Paid-In Capital 375.031 373.352 371.333 368.953 294.639
Retained Earnings (Accumulated Deficit) -364.467 -344.195 -321.11 -297.221 -274.179
Total Liabilities & Shareholders’ Equity 50.137 67.804 84.29 105.026 59.344
Total Common Shares Outstanding 42.596 42.5801 42.5714 42.4832 36.0228
Redeemable Preferred Stock 0 0
Other Current Assets, Total 0.254
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -90.288 -81.62 -86.331 -61.744 -27.559
Cash From Operating Activities -77.094 -61.518 -75.796 -46.316 -22.495
Cash From Operating Activities 2.358 1.823 1.318 0.792 0.316
Non-Cash Items 11.099 13.728 10.433 8.14 0.738
Cash Interest Paid 2.133 1.925 0.881 0.943 0.343
Changes in Working Capital -0.263 4.551 -1.216 6.496 4.01
Cash From Investing Activities -0.691 -4.024 -3.586 -3.002 -1.406
Capital Expenditures -1.129 -4.024 -3.586 -3.002 -1.406
Cash From Financing Activities 70.037 40.399 74.642 98.907 49.736
Financing Cash Flow Items -0.359 -0.079 -1.158 -1.84 0
Issuance (Retirement) of Stock, Net 70.396 40.546 68.391 100.852 39.86
Issuance (Retirement) of Debt, Net 0 -0.068 7.409 -0.105 9.876
Net Change in Cash -7.748 -25.143 -4.74 49.589 25.835
Other Investing Cash Flow Items, Total 0.438
Dec 2021 Sep 2021 Jun 2021 Mar 2021 Dec 2020
Net income/Starting Line -90.288 -70.016 -46.931 -23.042 -81.62
Cash From Operating Activities -77.094 -59.934 -44.057 -23.974 -61.518
Cash From Operating Activities 2.358 1.754 1.16 0.577 1.823
Non-Cash Items 11.099 9.331 7.146 4.603 13.728
Cash Interest Paid 2.133 1.601 1.064 0.526 1.925
Changes in Working Capital -0.263 -1.003 -5.432 -6.112 4.551
Cash From Investing Activities -0.691 -0.693 -0.262 -0.03 -4.024
Capital Expenditures -1.129 -0.693 -0.262 -0.03 -4.024
Cash From Financing Activities 70.037 70.062 70.076 70.144 40.399
Financing Cash Flow Items -0.359 -0.329 -0.31 -0.186 -0.079
Issuance (Retirement) of Stock, Net 70.396 70.391 70.386 70.33 40.546
Issuance (Retirement) of Debt, Net 0 0 0 -0.068
Net Change in Cash -7.748 9.435 25.757 46.14 -25.143
Other Investing Cash Flow Items, Total 0.438
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Menichella (Daniel L.) Individual Investor 0.2996 127700 107700 2022-03-31 MED
Duke (William E. Jr.) Individual Investor 0.1598 68115 68115 2022-03-31 LOW
Korn (Jerald) Individual Investor 0.1215 51803 51803 2022-03-31
Melas-Kyriazi (Theo) Individual Investor 0.0782 33333 0 2022-03-31 LOW
Quinn (Anthony G) Individual Investor 0.0741 31603 0 2022-03-31 LOW
Northern Trust Global Investments Investment Advisor 0.0334 14235 14235 2022-12-31 LOW
DWS Investments UK Limited Investment Advisor 0.0244 10387 0 2023-02-28 MED
Amalgamated Financial Corp. Investment Advisor 0.0077 3266 3266 2022-03-31
Mackenzie Financial Corporation Investment Advisor/Hedge Fund 0.0027 1139 -148 2022-09-30 LOW
Westfield Capital Management Company, L.P. Investment Advisor/Hedge Fund 0.002 854 0 2021-09-30 LOW
Carroll Financial Associates, Inc. Investment Advisor 0.0008 339 0 2021-12-31

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Biotechnology & Medical Research (NEC)

18 Crosby Dr
BEDFORD
MASSACHUSETTS 01730-1402
US

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

70.43 Price
+0.490% 1D Chg, %
Biaya inap posisi Long -0.0170%
Biaya inap posisi short -0.0050%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

XRP/USD

0.45 Price
+5.840% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00461

US100

12,677.90 Price
+0.890% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

BTC/USD

27,739.90 Price
+1.070% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda